Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (207)
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
53
Price
$43.54
Total Value
$2.31K
Shares Held After
390
% of Holdings
12.0%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
1,357
Price
$43.54
Total Value
$59.08K
Shares Held After
17,811
% of Holdings
7.1%
ENSIGN GROUP, INC (ENSG)
Parkinson Mark Vincent — Director
Shares
100
Price
$179.62
Total Value
$17.96K
Shares Held After
4,400
% of Holdings
2.2%
EXAGEN INC. (XGN)
ABALLI JOHN — Director
Shares
34,294
Price
$7.87
Total Value
$269.79K
Shares Held After
805,540
% of Holdings
4.1%
Guardant Health, Inc. (GH)
Tariq Musa — Director
Shares
116
Price
$165.88
Total Value
$19.24K
Shares Held After
11,583
% of Holdings
1.0%
Karyopharm Therapeutics Inc. (KPTI)
Abate Kristin — Chief Accounting Officer
Shares
4,788
Price
$0.34
Total Value
$1.65K
Shares Held After
18,616
% of Holdings
20.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$543.85
Total Value
$21.75K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
391
Price
$542.67
Total Value
$212.19K
Shares Held After
324,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
169
Price
$541.62
Total Value
$91.53K
Shares Held After
324,874
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
239
Price
$539.60
Total Value
$128.96K
Shares Held After
325,043
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
401
Price
$538.55
Total Value
$215.96K
Shares Held After
325,282
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
760
Price
$537.74
Total Value
$408.68K
Shares Held After
325,683
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
865
Price
$536.66
Total Value
$464.21K
Shares Held After
326,443
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
535
Price
$535.67
Total Value
$286.58K
Shares Held After
327,308
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$534.41
Total Value
$342.02K
Shares Held After
327,843
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,818
Price
$533.32
Total Value
$969.58K
Shares Held After
328,483
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,378
Price
$532.46
Total Value
$1.27M
Shares Held After
330,301
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,024
Price
$531.54
Total Value
$544.30K
Shares Held After
332,679
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$530.48
Total Value
$127.31K
Shares Held After
333,703
% of Holdings
0.1%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
25,000
Price
$23.98
Total Value
$599.60K
Shares Held After
1,047,205
% of Holdings
2.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
300
Price
$25.45
Total Value
$7.63K
Shares Held After
377,802
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
11,581
Price
$24.21
Total Value
$280.38K
Shares Held After
378,102
% of Holdings
3.0%
DEXCOM INC (DXCM)
Brown Michael Jon — EVP Chief Legal Compliance Off
Shares
1,700
Price
$85.48
Total Value
$145.32K
Shares Held After
98,185
% of Holdings
1.7%
Septerna, Inc. (SEPN)
Bhatt Elizabeth — President and COO
Shares
2,906
Price
$37.61
Total Value
$109.31K
Shares Held After
174,209
% of Holdings
1.6%
Septerna, Inc. (SEPN)
Bhatt Elizabeth — President and COO
Shares
1,094
Price
$36.87
Total Value
$40.34K
Shares Held After
177,115
% of Holdings
0.6%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Reynoso Jamie L. — CEO, Medicare Advantage
Shares
18,273
Price
$4.68
Total Value
$85.52K
Shares Held After
2,774,417
% of Holdings
0.7%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, Global Head of R&D
Shares
2,642
Price
$112.71
Total Value
$297.78K
Shares Held After
183,200
% of Holdings
1.4%
MCKESSON CORP (MCK)
Fraga Francisco — EVP, CIO and CTO
Shares
800
Price
$995.80
Total Value
$797.13K
Shares Held After
5,423
% of Holdings
12.9%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
4,728
Price
$26.93
Total Value
$127.33K
Shares Held After
35,207
% of Holdings
11.8%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
78,400
Price
$55.02
Total Value
$4.31M
Shares Held After
432,886
% of Holdings
15.3%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
37,270
Price
$54.20
Total Value
$2.02M
Shares Held After
511,286
% of Holdings
6.8%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
128,065
Price
$52.97
Total Value
$6.78M
Shares Held After
548,556
% of Holdings
18.9%
Elanco Animal Health Inc (ELAN)
Bettington Timothy J — Executive Vice President, Center of Strategic Growth
Exhibit List: Exhibit 24-Power of Attorney
Shares
4,350
Price
$23.00
Total Value
$100.05K
Shares Held After
138,911
% of Holdings
3.0%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Wai Conrad — CEO, Counterpart Health
Shares
23,627
Price
$4.68
Total Value
$110.57K
Shares Held After
1,042,072
% of Holdings
2.2%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
THORNTON JOSEPH CLAY — Interim CFO
Shares
4,591
Price
$4.68
Total Value
$21.49K
Shares Held After
1,244,935
% of Holdings
0.4%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Soares Karen — Chief Legal Officer
Shares
14,673
Price
$4.68
Total Value
$68.67K
Shares Held After
1,592,698
% of Holdings
0.9%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
500
Price
$62.48
Total Value
$31.24K
Shares Held After
0
% of Holdings
100.0%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
500
Price
$61.65
Total Value
$30.82K
Shares Held After
500
% of Holdings
50.0%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Toy Andrew — Director
Shares
62,176
Price
$4.68
Total Value
$290.98K
Shares Held After
9,078,334
% of Holdings
0.7%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
7,066
Price
$15.27
Total Value
$107.90K
Shares Held After
89,229
% of Holdings
7.3%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
2,000
Price
$408.24
Total Value
$816.47K
Shares Held After
2,119,394
% of Holdings
0.1%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
3,800
Price
$407.27
Total Value
$1.55M
Shares Held After
2,121,394
% of Holdings
0.2%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
1,400
Price
$406.63
Total Value
$569.28K
Shares Held After
2,125,194
% of Holdings
0.1%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
6,274
Price
$405.18
Total Value
$2.54M
Shares Held After
2,126,594
% of Holdings
0.3%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
10,321
Price
$404.64
Total Value
$4.18M
Shares Held After
2,132,868
% of Holdings
0.5%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
3,858
Price
$403.27
Total Value
$1.56M
Shares Held After
2,143,189
% of Holdings
0.2%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
6,309
Price
$402.23
Total Value
$2.54M
Shares Held After
2,147,047
% of Holdings
0.3%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
5,974
Price
$401.42
Total Value
$2.40M
Shares Held After
2,153,356
% of Holdings
0.3%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
2,671
Price
$400.31
Total Value
$1.07M
Shares Held After
2,159,330
% of Holdings
0.1%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
793
Price
$399.31
Total Value
$316.66K
Shares Held After
2,162,001
% of Holdings
0.0%
207 transactions